The long term goal is the elucidation of the functional significance of specific carcinogen-protein interactions in liver carcinogenesis. Our recent findings have determined that the principal target of a hepatic carcinogen, N-2-fluorenylacetamide (FAA; 2-acetylaminofluorene), is a liver cytoplasmic 14,000-dalton polypeptide that is specifically associated with mitosis in normal adult rat hepatocytes, and with early and persistent foci of hyperplasia of hepatocytes caused by the two carcinogens, FAA and 3'-methyl-4-dimethyl-aminoazobenzene. A 17,500-dalton polypeptide that is related to the cytoplasmic 14,000-dalton target polypeptide is tightly bound to chromatin in normal adult rat liver. Mitosis in normal adult hepatocytes is associated with a marked elevation in the apparent level of the 14,000-dalton polypeptide in cytoplasm. In addition, feeding of either of the two hepatocarcinogens causes early and persistent polypeptide foci of hepatocytes, in which there appears to be a great overload of the 14,000-dalton polypeptide in cytoplasm, and a near absence of 17,500-dalton polypeptide in most nuclei. Our hypothesis is that the cytoplasmic 14,000-dalton polypeptide target of the hepatic carcinogen has a positive but unknown function in cell multiplication in normal adult hepatocytes, and in liver oncogenesis by these carcinogens. The proposed research will purify the two polypeptides or their fragments in forms suitable for physical, chemical and immunological characterizations. In search of the identities of the two polypeptides and their physiological interrelationships, their amino acid sequences will be determined, evaluated for homology between them, and searched for matches or relatedness to known protein and nucleic acid sequences in large computer databases. The ability of the nuclear 17,500-dalton polypeptide to bind DNA in a specific manner will be investigated. The rates of turnover of the two polypeptides, and their initial rates of accumulation will be examined in livers of rats. The relationships of the early and persistent polypeptide foci of hepatocytes to liver neoplasia caused by the two carcinogens will be investigated. The extent to which the nuclear 17,500-dalton polypeptide may be a direct target of FAA will be directly examined. Finally, histochemical staining methods will quantitatively establish the degrees to which the early and the persistent polypeptide foci overlap with the islands of hyperplastic hepatocytes and with foci of elevated gamma-glutamyl transpeptidase activity during hepatocarcinogenesis in rats. It seems reasonable to speculate that future manipulations of the levels of the two polypeptides in normal and preneoplastic hepatocytes may possibly provide new approaches to the prevention or cessation of the early processes that lead to liver neoplasia in animals and humans.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA005945-21
Application #
3163210
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1978-12-01
Project End
1988-08-31
Budget Start
1985-09-15
Budget End
1986-08-31
Support Year
21
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Institute for Cancer Research
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Sorof, S (1994) Modulation of mitogenesis by liver fatty acid binding protein. Cancer Metastasis Rev 13:317-36
Khan, S H; Sorof, S (1994) Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc Natl Acad Sci U S A 91:848-52
Keler, T; Sorof, S (1993) Growth promotion of transfected hepatoma cells by liver fatty acid binding protein. J Cell Physiol 157:33-40
Keler, T; Barker, C S; Sorof, S (1992) Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen. Proc Natl Acad Sci U S A 89:4830-4
Khan, S H; Sorof, S (1990) Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. Proc Natl Acad Sci U S A 87:9401-5
Raza, H; Pongubala, J R; Sorof, S (1989) Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein. Biochem Biophys Res Commun 161:448-55
Munir, K M; Custer, R P; Sorof, S (1989) Normal hepatocytes exhibiting histone H3 with antibody accessible sites that are cryptic in carcinogen-altered hepatocytes. Cancer Res 49:424-32
Munir, K M; Blackburn, G R; Sorof, S (1988) Late target protein of the carcinogen N-2-fluorenylacetamide in rat liver. Cancer Res 48:6745-52
Bassuk, J A; Tsichlis, P N; Sorof, S (1987) Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes. Proc Natl Acad Sci U S A 84:7547-51
Sorof, S; Custer, R P (1987) Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes. Cancer Res 47:210-20

Showing the most recent 10 out of 14 publications